Close Menu

NEW YORK (360DX) – Texas-based United Allergy Services filed suit against Quest Diagnostics late last month, accusing the lab giant of conspiring with other market players to eliminate lower-priced competition.

The allergy company alleges that Quest and co-conspirators have cost the company $200 million in lost profits. Specifically, the suit alleges that Quest and other players in the industry convinced insurers and potential UAS customers that doing business with UAS "caused medical, legal and other risks."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.